First Parkinson's Patient Receives iPS Cell Treatment at Kyoto University Hospital

Japanese pharmaceutical company Sumitomo Pharma announced on October 30 that the first patient to receive its newly approved regenerative medicine treatment for Parkinson's disease underwent a successful brain cell transplant at Kyoto University Hospital in early October, with the woman in her 50s already returning to work and recovering well. (News On Japan)

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.